Reese DM - Search Results

1

HER-2/neu signal transduction in human breast and ovarian cancer.

Reese DM, Slamon DJ. Reese DM, et al. Stem Cells. 1997;15(1):1-8. doi: 10.1002/stem.150001. Stem Cells. 1997. PMID: 9007217 Review.

2

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ. Pietras RJ, et al. Among authors: reese dm. Oncogene. 1995 Jun 15;10(12):2435-46. Oncogene. 1995. PMID: 7784095

3

Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.

Pegram MD, Pienkowski T, Northfelt DW, Eiermann W, Patel R, Fumoleau P, Quan E, Crown J, Toppmeyer D, Smylie M, Riva A, Blitz S, Press MF, Reese D, Lindsay MA, Slamon DJ. Pegram MD, et al. J Natl Cancer Inst. 2004 May 19;96(10):759-69. doi: 10.1093/jnci/djh133. J Natl Cancer Inst. 2004. PMID: 15150304 Clinical Trial.

4

Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.

Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M, Slamon D. Strohmeyer T, et al. J Urol. 1995 Feb;153(2):511-5. doi: 10.1097/00005392-199502000-00073. J Urol. 1995. PMID: 7529338

5

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.

Wilson CA, Payton MN, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, Reese DM, Slamon DJ, Calzone FJ. Wilson CA, et al. Among authors: reese dm. Oncogene. 1997 Jan 9;14(1):1-16. doi: 10.1038/sj.onc.1200924. Oncogene. 1997. PMID: 9010228

6

Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor.

Pegram MD, Reese DM. Pegram MD, et al. Among authors: reese dm. Semin Oncol. 2002 Jun;29(3 Suppl 11):29-37. doi: 10.1053/sonc.2002.34053. Semin Oncol. 2002. PMID: 12138395 Review.

7

HER2-positive breast cancer: update on Breast Cancer International Research Group trials.

Nabholtz JM, Reese DM, Lindsay MA, Riva A. Nabholtz JM, et al. Among authors: reese dm. Clin Breast Cancer. 2002 Oct;3 Suppl 2:S75-9. doi: 10.3816/cbc.2002.s.016. Clin Breast Cancer. 2002. PMID: 12435291 Review.

8

Evidence for the use of chemotherapy in breast cancer.

Nabholtz JM, Reese D, Lindsay MA, Riva A. Nabholtz JM, et al. Int J Clin Oncol. 2002 Aug;7(4):254-64. doi: 10.1007/s101470200037. Int J Clin Oncol. 2002. PMID: 12202979 Review.

9

HER2 protein expression and gene amplification in androgen-independent prostate cancer.

Reese DM, Small EJ, Magrane G, Waldman FM, Chew K, Sudilovsky D. Reese DM, et al. Am J Clin Pathol. 2001 Aug;116(2):234-9. doi: 10.1309/VXKK-YVRH-9B11-YDPT. Am J Clin Pathol. 2001. PMID: 11488070

10

Anastrozole in the management of breast cancer.

Nabholtz JM, Reese D. Nabholtz JM, et al. Expert Opin Pharmacother. 2002 Sep;3(9):1329-39. doi: 10.1517/14656566.3.9.1329. Expert Opin Pharmacother. 2002. PMID: 12186625 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters